LNSR
LENSAR Inc
Halal Rating :
Last Price
$8.30
Last updated:
Market Cap
-
7D Change
2.98%
1 Year Change
135.13%
Company Overview
Industries
Exchange
Next Earnings Date
LENSAR, Inc. is a commercial-stage medical device company focusing on designing, developing, and marketing advanced femtosecond laser systems for the treatment of cataracts and the management of pre-existing or surgically induced corneal astigmatism. Their primary product is the LENSAR Laser System with Streamline IV, which enables surgeons to provide treatment options for their patients who have cataracts.
Use of Interest
| Reporting Date | Total Revenue | Total Operating Expense | Interest Income | Interest Expense | Interest Income Ratio | Interest Expense Ratio |
|---|---|---|---|---|---|---|
| Sept. 30, 2024 | $13.54m | $14.78m | - | - | 0.00% | 0.00% |
| June 30, 2024 | $12.64m | $17.92m | - | - | 0.00% | 0.00% |
| March 31, 2024 | $10.59m | $13.44m | - | - | 0.00% | 0.00% |
Company Impact
Help us evaluate LENSAR Inc's impact from a halal perspective. Vote on the most significant aspect and submit any considerations that we may have missed.